APO Research
Talk to an analyst

APO RESEARCH · REPORT

Anti-Viral Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Anti-Viral Drugs Industry Growth and Trends Forecast to 2032

20 December 202599 pages

Choose your research edition.

Industry ResearchAnti-Viral Drugs Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Anti-Viral Drugs Industry Growth and Trends Forecast to 203299 pages · $3,450 USDMarket StructureGlobal Anti-Viral Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Anti-Viral Drugs Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Anti-Viral Drugs Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Anti-Viral Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Anti-Viral Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Anti-Viral Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Anti-Viral Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Anti-Viral Drugs include Aurobindo Pharma, Bristol-Myers-Squibb, Cipla, Dr Reddy’s, F. Hoffmann-La Roche, AbbVie, GlaxoSmithKline, Merck & Co and Johnson & Johnson, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Anti-Viral Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Anti-Viral Drugs market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Anti-Viral Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Anti-Viral Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Anti-Viral Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Anti-Viral Drugs Market by Company

Aurobindo Pharma

Bristol-Myers-Squibb

Cipla

Dr Reddy’s

F. Hoffmann-La Roche

AbbVie

GlaxoSmithKline

Merck & Co

Johnson & Johnson

Anti-Viral Drugs Segment by Type

Reverse Transcriptase Inhibitor

Nucleotide Polymerase Inhibitor

Protease Inhibitor

Anti-Viral Drugs Segment by Application

HIV

Influenza

Hepatitis

HSV

Anti-Viral Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anti-Viral Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Anti-Viral Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anti-Viral Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Anti-Viral Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Anti-Viral Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Reverse Transcriptase Inhibitor Table 2. Major Company of Nucleotide Polymerase Inhibitor Table 3. Major Company of Protease Inhibitor Table 4. Global Anti-Viral Drugs Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Anti-Viral Drugs Sales by Type (2021-2026) & (K Units) Table 6. Global Anti-Viral Drugs Sales Market Share in Volume by Type (2021-2026) Table 7. Global Anti-Viral Drugs Sales by Type (2021-2026) & (US$ Million) Table 8. Global Anti-Viral Drugs Sales Market Share in Value by Type (2021-2026) Table 9. Global Anti-Viral Drugs Price by Type (2021-2026) & (US$/Unit) Table 10. Global Anti-Viral Drugs Sales by Type (2027-2032) & (K Units) Table 11. Global Anti-Viral Drugs Sales Market Share in Volume by Type (2027-2032) Table 12. Global Anti-Viral Drugs Sales by Type (2027-2032) & (US$ Million) Table 13. Global Anti-Viral Drugs Sales Market Share in Value by Type (2027-2032) Table 14. Global Anti-Viral Drugs Price by Type (2027-2032) & (US$/Unit) Table 15. North America Anti-Viral Drugs Sales by Type (2021-2026) & (K Units) Table 16. North America Anti-Viral Drugs Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Anti-Viral Drugs Sales by Type (2021-2026) & (K Units) Table 18. Europe Anti-Viral Drugs Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Anti-Viral Drugs Sales by Type (2021-2026) & (K Units) Table 20. Asia-Pacific Anti-Viral Drugs Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Anti-Viral Drugs Sales by Type (2021-2026) & (K Units) Table 22. Latin America Anti-Viral Drugs Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Anti-Viral Drugs Sales by Type (2021-2026) & (K Units) Table 24. Middle East and Africa Anti-Viral Drugs Sales by Type (2021-2026) & (US$ Million) Table 25. Anti-Viral Drugs Industry Trends Table 26. Anti-Viral Drugs Industry Drivers Table 27. Anti-Viral Drugs Industry Opportunities and Challenges Table 28. Anti-Viral Drugs Industry Restraints Table 29. Global Anti-Viral Drugs Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Anti-Viral Drugs Revenue Market Share by Company (2021-2026) Table 31. Global Anti-Viral Drugs Sales by Company (2021-2026) & (K Units) Table 32. Global Anti-Viral Drugs Sales Share by Company (2021-2026) Table 33. Global Anti-Viral Drugs Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Anti-Viral Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Anti-Viral Drugs Major Company Production Sites and Headquarters Table 36. Global Anti-Viral Drugs Company, Product Type & Application Table 37. Global Anti-Viral Drugs Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Anti-Viral Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Anti-Viral Drugs Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Anti-Viral Drugs Sales by Region (2021-2026) & (K Units) Table 42. Global Anti-Viral Drugs Sales Market Share in Volume by Region (2021-2026) Table 43. Global Anti-Viral Drugs Sales by Region (2021-2026) & (US$ Million) Table 44. Global Anti-Viral Drugs Sales Market Share in Value by Region (2021-2026) Table 45. Global Anti-Viral Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Anti-Viral Drugs Sales by Region (2027-2032) & (K Units) Table 47. Global Anti-Viral Drugs Sales Market Share in Volume by Region (2027-2032) Table 48. Global Anti-Viral Drugs Sales by Region (2027-2032) & (US$ Million) Table 49. Global Anti-Viral Drugs Sales Market Share in Value by Region (2027-2032) Table 50. Global Anti-Viral Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Anti-Viral Drugs Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Anti-Viral Drugs Sales by Application (2021-2026) & (K Units) Table 53. Global Anti-Viral Drugs Sales Market Share in Volume by Application (2021-2026) Table 54. Global Anti-Viral Drugs Sales by Application (2021-2026) & (US$ Million) Table 55. Global Anti-Viral Drugs Sales Market Share in Value by Application (2021-2026) Table 56. Global Anti-Viral Drugs Price by Application (2021-2026) & (US$/Unit) Table 57. Global Anti-Viral Drugs Sales by Application (2027-2032) & (K Units) Table 58. Global Anti-Viral Drugs Sales Market Share in Volume by Application (2027-2032) Table 59. Global Anti-Viral Drugs Sales by Application (2027-2032) & (US$ Million) Table 60. Global Anti-Viral Drugs Sales Market Share in Value by Application (2027-2032) Table 61. Global Anti-Viral Drugs Price by Application (2027-2032) & (US$/Unit) Table 62. North America Anti-Viral Drugs Sales by Application (2021-2026) & (K Units) Table 63. North America Anti-Viral Drugs Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Anti-Viral Drugs Sales by Application (2021-2026) & (K Units) Table 65. Europe Anti-Viral Drugs Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Anti-Viral Drugs Sales by Application (2021-2026) & (K Units) Table 67. Asia-Pacific Anti-Viral Drugs Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Anti-Viral Drugs Sales by Application (2021-2026) & (K Units) Table 69. Latin America Anti-Viral Drugs Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Anti-Viral Drugs Sales by Application (2021-2026) & (K Units) Table 71. Middle East and Africa Anti-Viral Drugs Sales by Application (2021-2026) & (US$ Million) Table 72. Aurobindo Pharma Company Information Table 73. Aurobindo Pharma Business Overview Table 74. Aurobindo Pharma Anti-Viral Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Aurobindo Pharma Anti-Viral Drugs Product Portfolio Table 76. Aurobindo Pharma Recent Development Table 77. Bristol-Myers-Squibb Company Information Table 78. Bristol-Myers-Squibb Business Overview Table 79. Bristol-Myers-Squibb Anti-Viral Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Bristol-Myers-Squibb Anti-Viral Drugs Product Portfolio Table 81. Bristol-Myers-Squibb Recent Development Table 82. Cipla Company Information Table 83. Cipla Business Overview Table 84. Cipla Anti-Viral Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Cipla Anti-Viral Drugs Product Portfolio Table 86. Cipla Recent Development Table 87. Dr Reddy’s Company Information Table 88. Dr Reddy’s Business Overview Table 89. Dr Reddy’s Anti-Viral Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Dr Reddy’s Anti-Viral Drugs Product Portfolio Table 91. Dr Reddy’s Recent Development Table 92. F. Hoffmann-La Roche Company Information Table 93. F. Hoffmann-La Roche Business Overview Table 94. F. Hoffmann-La Roche Anti-Viral Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. F. Hoffmann-La Roche Anti-Viral Drugs Product Portfolio Table 96. F. Hoffmann-La Roche Recent Development Table 97. AbbVie Company Information Table 98. AbbVie Business Overview Table 99. AbbVie Anti-Viral Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. AbbVie Anti-Viral Drugs Product Portfolio Table 101. AbbVie Recent Development Table 102. GlaxoSmithKline Company Information Table 103. GlaxoSmithKline Business Overview Table 104. GlaxoSmithKline Anti-Viral Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. GlaxoSmithKline Anti-Viral Drugs Product Portfolio Table 106. GlaxoSmithKline Recent Development Table 107. Merck & Co Company Information Table 108. Merck & Co Business Overview Table 109. Merck & Co Anti-Viral Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Merck & Co Anti-Viral Drugs Product Portfolio Table 111. Merck & Co Recent Development Table 112. Johnson & Johnson Company Information Table 113. Johnson & Johnson Business Overview Table 114. Johnson & Johnson Anti-Viral Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Johnson & Johnson Anti-Viral Drugs Product Portfolio Table 116. Johnson & Johnson Recent Development Table 117. North America Anti-Viral Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 118. North America Anti-Viral Drugs Sales by Country (2021-2026) & (K Units) Table 119. North America Anti-Viral Drugs Sales Market Share by Country (2021-2026) Table 120. North America Anti-Viral Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 121. North America Anti-Viral Drugs Sales Market Share Forecast by Country (2027-2032) Table 122. North America Anti-Viral Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 123. North America Anti-Viral Drugs Market Size by Country (2021-2026) & (US$ Million) Table 124. North America Anti-Viral Drugs Market Share by Country (2021-2026) Table 125. North America Anti-Viral Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 126. North America Anti-Viral Drugs Market Share Forecast by Country (2027-2032) Table 127. Europe Anti-Viral Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 128. Europe Anti-Viral Drugs Sales by Country (2021-2026) & (K Units) Table 129. Europe Anti-Viral Drugs Sales Market Share by Country (2021-2026) Table 130. Europe Anti-Viral Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 131. Europe Anti-Viral Drugs Sales Market Share Forecast by Country (2027-2032) Table 132. Europe Anti-Viral Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 133. Europe Anti-Viral Drugs Market Size by Country (2021-2026) & (US$ Million) Table 134. Europe Anti-Viral Drugs Market Share by Country (2021-2026) Table 135. Europe Anti-Viral Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 136. Europe Anti-Viral Drugs Market Share Forecast by Country (2027-2032) Table 137. Asia-Pacific Anti-Viral Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 138. Asia-Pacific Anti-Viral Drugs Sales by Country (2021-2026) & (K Units) Table 139. Asia-Pacific Anti-Viral Drugs Sales Market Share by Country (2021-2026) Table 140. Asia-Pacific Anti-Viral Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 141. Asia-Pacific Anti-Viral Drugs Sales Market Share Forecast by Country (2027-2032) Table 142. Asia-Pacific Anti-Viral Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 143. Asia-Pacific Anti-Viral Drugs Market Size by Country (2021-2026) & (US$ Million) Table 144. Asia-Pacific Anti-Viral Drugs Market Share by Country (2021-2026) Table 145. Asia-Pacific Anti-Viral Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 146. Asia-Pacific Anti-Viral Drugs Market Share Forecast by Country (2027-2032) Table 147. Latin America Anti-Viral Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 148. Latin America Anti-Viral Drugs Sales by Country (2021-2026) & (K Units) Table 149. Latin America Anti-Viral Drugs Sales Market Share by Country (2021-2026) Table 150. Latin America Anti-Viral Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 151. Latin America Anti-Viral Drugs Sales Market Share Forecast by Country (2027-2032) Table 152. Latin America Anti-Viral Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 153. Latin America Anti-Viral Drugs Market Size by Country (2021-2026) & (US$ Million) Table 154. Latin America Anti-Viral Drugs Market Share by Country (2021-2026) Table 155. Latin America Anti-Viral Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 156. Latin America Anti-Viral Drugs Market Share Forecast by Country (2027-2032) Table 157. Middle East and Africa Anti-Viral Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 158. Middle East and Africa Anti-Viral Drugs Sales by Country (2021-2026) & (K Units) Table 159. Middle East and Africa Anti-Viral Drugs Sales Market Share by Country (2021-2026) Table 160. Middle East and Africa Anti-Viral Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 161. Middle East and Africa Anti-Viral Drugs Sales Market Share Forecast by Country (2027-2032) Table 162. Middle East and Africa Anti-Viral Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 163. Middle East and Africa Anti-Viral Drugs Market Size by Country (2021-2026) & (US$ Million) Table 164. Middle East and Africa Anti-Viral Drugs Market Share by Country (2021-2026) Table 165. Middle East and Africa Anti-Viral Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 166. Middle East and Africa Anti-Viral Drugs Market Share Forecast by Country (2027-2032) Table 167. Key Raw Materials Table 168. Raw Materials Key Suppliers Table 169. Anti-Viral Drugs Distributors List Table 170. Anti-Viral Drugs Customers List Table 171. Research Programs/Design for This Report Table 172. Authors List of This Report Table 173. Secondary Sources Table 174. Primary Sources List of Figures Figure 1. Anti-Viral Drugs Image Figure 2. Global Anti-Viral Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Anti-Viral Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Anti-Viral Drugs Sales (2021-2032) & (K Units) Figure 5. Reverse Transcriptase Inhibitor Image Figure 6. Global Reverse Transcriptase Inhibitor Sales YoY Growth (2021-2032) & (K Units) Figure 7. Nucleotide Polymerase Inhibitor Image Figure 8. Global Nucleotide Polymerase Inhibitor Sales YoY Growth (2021-2032) & (K Units) Figure 9. Protease Inhibitor Image Figure 10. Global Protease Inhibitor Sales YoY Growth (2021-2032) & (K Units) Figure 11. Global Anti-Viral Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Anti-Viral Drugs Market Share by Type 2025 VS 2032 Figure 13. North America Anti-Viral Drugs Sales Market Share in Volume by Type in 2025 Figure 14. North America Anti-Viral Drugs Sales Market Share in Value by Type in 2025 Figure 15. Europe Anti-Viral Drugs Sales Market Share in Volume by Type in 2025 Figure 16. Europe Anti-Viral Drugs Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Anti-Viral Drugs Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Anti-Viral Drugs Sales Market Share in Value by Type in 2025 Figure 19. Latin America Anti-Viral Drugs Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Anti-Viral Drugs Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Anti-Viral Drugs Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Anti-Viral Drugs Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Anti-Viral Drugs Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. HIV Image Figure 26. Global HIV Sales YoY Growth (2021-2032) & (K Units) Figure 27. Influenza Image Figure 28. Global Influenza Sales YoY Growth (2021-2032) & (K Units) Figure 29. Hepatitis Image Figure 30. Global Hepatitis Sales YoY Growth (2021-2032) & (K Units) Figure 31. HSV Image Figure 32. Global HSV Sales YoY Growth (2021-2032) & (K Units) Figure 33. Global Anti-Viral Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Anti-Viral Drugs Market Share by Application 2025 VS 2032 Figure 35. North America Anti-Viral Drugs Sales Market Share in Volume by Application in 2025 Figure 36. North America Anti-Viral Drugs Sales Market Share in Value by Application in 2025 Figure 37. Europe Anti-Viral Drugs Sales Market Share in Volume by Application in 2025 Figure 38. Europe Anti-Viral Drugs Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Anti-Viral Drugs Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Anti-Viral Drugs Sales Market Share in Value by Application in 2025 Figure 41. Latin America Anti-Viral Drugs Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Anti-Viral Drugs Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Anti-Viral Drugs Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Anti-Viral Drugs Sales Market Share in Value by Application in 2025 Figure 45. North America Anti-Viral Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. North America Anti-Viral Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Anti-Viral Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Anti-Viral Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Anti-Viral Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Europe Anti-Viral Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Anti-Viral Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Anti-Viral Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Anti-Viral Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Asia-Pacific Anti-Viral Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Anti-Viral Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Anti-Viral Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Anti-Viral Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Latin America Anti-Viral Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Anti-Viral Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Anti-Viral Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Anti-Viral Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 62. Middle East and Africa Anti-Viral Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Anti-Viral Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Anti-Viral Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Anti-Viral Drugs Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Anti-Viral Drugs Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Reverse Transcriptase Inhibitor
  • Nucleotide Polymerase Inhibitor
  • Protease Inhibitor
Applications
  • HIV
  • Influenza
  • Hepatitis
  • HSV
Companies covered
  • Aurobindo Pharma
  • Bristol-Myers-Squibb
  • Cipla
  • Dr Reddy’s
  • F. Hoffmann-La Roche
  • AbbVie
  • GlaxoSmithKline
  • Merck & Co
  • Johnson & Johnson

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Anti-Viral Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Anti-Viral Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Anti-Viral Drugs Market by Type
  6. 1.3.1 Reverse Transcriptase Inhibitor
  7. 1.3.2 Nucleotide Polymerase Inhibitor
  8. 1.3.3 Protease Inhibitor
  9. 1.4 Global Anti-Viral Drugs Market Size by Type
  10. 1.4.1 Global Anti-Viral Drugs Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Anti-Viral Drugs Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Anti-Viral Drugs Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Anti-Viral Drugs Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Anti-Viral Drugs Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Anti-Viral Drugs Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Anti-Viral Drugs Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Anti-Viral Drugs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Anti-Viral Drugs Industry Trends
  2. 2.2 Anti-Viral Drugs Industry Drivers
  3. 2.3 Anti-Viral Drugs Industry Opportunities and Challenges
  4. 2.4 Anti-Viral Drugs Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Anti-Viral Drugs Revenue (2021-2026)
  2. 3.2 Global Top Players by Anti-Viral Drugs Sales (2021-2026)
  3. 3.3 Global Top Players by Anti-Viral Drugs Price (2021-2026)
  4. 3.4 Global Anti-Viral Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Anti-Viral Drugs Major Company Production Sites & Headquarters
  6. 3.6 Global Anti-Viral Drugs Company, Product Type & Application
  7. 3.7 Global Anti-Viral Drugs Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Anti-Viral Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Anti-Viral Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Anti-Viral Drugs Tier 1, Tier 2, and Tier 3
4 Anti-Viral Drugs Regional Status and Outlook
  1. 4.1 Global Anti-Viral Drugs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Anti-Viral Drugs Historic Market Size by Region
  3. 4.2.1 Global Anti-Viral Drugs Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Anti-Viral Drugs Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Anti-Viral Drugs Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Anti-Viral Drugs Forecasted Market Size by Region
  7. 4.3.1 Global Anti-Viral Drugs Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Anti-Viral Drugs Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Anti-Viral Drugs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Anti-Viral Drugs by Application
  1. 5.1 Anti-Viral Drugs Market by Application
  2. 5.1.1 HIV
  3. 5.1.2 Influenza
  4. 5.1.3 Hepatitis
  5. 5.1.4 HSV
  6. 5.2 Global Anti-Viral Drugs Market Size by Application
  7. 5.2.1 Global Anti-Viral Drugs Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Anti-Viral Drugs Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Anti-Viral Drugs Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Anti-Viral Drugs Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Anti-Viral Drugs Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Anti-Viral Drugs Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Anti-Viral Drugs Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Anti-Viral Drugs Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Aurobindo Pharma
  2. 6.1.1 Aurobindo Pharma Company Information
  3. 6.1.2 Aurobindo Pharma Business Overview
  4. 6.1.3 Aurobindo Pharma Anti-Viral Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Aurobindo Pharma Anti-Viral Drugs Product Portfolio
  6. 6.1.5 Aurobindo Pharma Recent Developments
  7. 6.2 Bristol-Myers-Squibb
  8. 6.2.1 Bristol-Myers-Squibb Company Information
  9. 6.2.2 Bristol-Myers-Squibb Business Overview
  10. 6.2.3 Bristol-Myers-Squibb Anti-Viral Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Bristol-Myers-Squibb Anti-Viral Drugs Product Portfolio
  12. 6.2.5 Bristol-Myers-Squibb Recent Developments
  13. 6.3 Cipla
  14. 6.3.1 Cipla Company Information
  15. 6.3.2 Cipla Business Overview
  16. 6.3.3 Cipla Anti-Viral Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Cipla Anti-Viral Drugs Product Portfolio
  18. 6.3.5 Cipla Recent Developments
  19. 6.4 Dr Reddy’s
  20. 6.4.1 Dr Reddy’s Company Information
  21. 6.4.2 Dr Reddy’s Business Overview
  22. 6.4.3 Dr Reddy’s Anti-Viral Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Dr Reddy’s Anti-Viral Drugs Product Portfolio
  24. 6.4.5 Dr Reddy’s Recent Developments
  25. 6.5 F. Hoffmann-La Roche
  26. 6.5.1 F. Hoffmann-La Roche Company Information
  27. 6.5.2 F. Hoffmann-La Roche Business Overview
  28. 6.5.3 F. Hoffmann-La Roche Anti-Viral Drugs Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 F. Hoffmann-La Roche Anti-Viral Drugs Product Portfolio
  30. 6.5.5 F. Hoffmann-La Roche Recent Developments
  31. 6.6 AbbVie
  32. 6.6.1 AbbVie Company Information
  33. 6.6.2 AbbVie Business Overview
  34. 6.6.3 AbbVie Anti-Viral Drugs Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 AbbVie Anti-Viral Drugs Product Portfolio
  36. 6.6.5 AbbVie Recent Developments
  37. 6.7 GlaxoSmithKline
  38. 6.7.1 GlaxoSmithKline Company Information
  39. 6.7.2 GlaxoSmithKline Business Overview
  40. 6.7.3 GlaxoSmithKline Anti-Viral Drugs Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 GlaxoSmithKline Anti-Viral Drugs Product Portfolio
  42. 6.7.5 GlaxoSmithKline Recent Developments
  43. 6.8 Merck & Co
  44. 6.8.1 Merck & Co Company Information
  45. 6.8.2 Merck & Co Business Overview
  46. 6.8.3 Merck & Co Anti-Viral Drugs Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Merck & Co Anti-Viral Drugs Product Portfolio
  48. 6.8.5 Merck & Co Recent Developments
  49. 6.9 Johnson & Johnson
  50. 6.9.1 Johnson & Johnson Company Information
  51. 6.9.2 Johnson & Johnson Business Overview
  52. 6.9.3 Johnson & Johnson Anti-Viral Drugs Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Johnson & Johnson Anti-Viral Drugs Product Portfolio
  54. 6.9.5 Johnson & Johnson Recent Developments
7 North America by Country
  1. 7.1 North America Anti-Viral Drugs Sales by Country
  2. 7.1.1 North America Anti-Viral Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Anti-Viral Drugs Sales by Country (2021-2026)
  4. 7.1.3 North America Anti-Viral Drugs Sales Forecast by Country (2027-2032)
  5. 7.2 North America Anti-Viral Drugs Market Size by Country
  6. 7.2.1 North America Anti-Viral Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Anti-Viral Drugs Market Size by Country (2021-2026)
  8. 7.2.3 North America Anti-Viral Drugs Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Anti-Viral Drugs Sales by Country
  2. 8.1.1 Europe Anti-Viral Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Anti-Viral Drugs Sales by Country (2021-2026)
  4. 8.1.3 Europe Anti-Viral Drugs Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Anti-Viral Drugs Market Size by Country
  6. 8.2.1 Europe Anti-Viral Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Anti-Viral Drugs Market Size by Country (2021-2026)
  8. 8.2.3 Europe Anti-Viral Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Anti-Viral Drugs Sales by Country
  2. 9.1.1 Asia-Pacific Anti-Viral Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Anti-Viral Drugs Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Anti-Viral Drugs Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Anti-Viral Drugs Market Size by Country
  6. 9.2.1 Asia-Pacific Anti-Viral Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Anti-Viral Drugs Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Anti-Viral Drugs Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Anti-Viral Drugs Sales by Country
  2. 10.1.1 South America Anti-Viral Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Anti-Viral Drugs Sales by Country (2021-2026)
  4. 10.1.3 South America Anti-Viral Drugs Sales Forecast by Country (2027-2032)
  5. 10.2 South America Anti-Viral Drugs Market Size by Country
  6. 10.2.1 South America Anti-Viral Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Anti-Viral Drugs Market Size by Country (2021-2026)
  8. 10.2.3 South America Anti-Viral Drugs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Anti-Viral Drugs Sales by Country
  2. 11.1.1 Middle East and Africa Anti-Viral Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Anti-Viral Drugs Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Anti-Viral Drugs Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Anti-Viral Drugs Market Size by Country
  6. 11.2.1 Middle East and Africa Anti-Viral Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Anti-Viral Drugs Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Anti-Viral Drugs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Anti-Viral Drugs Value Chain Analysis
  2. 12.1.1 Anti-Viral Drugs Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Anti-Viral Drugs Production Mode & Process
  7. 12.2 Anti-Viral Drugs Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Anti-Viral Drugs Distributors
  10. 12.2.3 Anti-Viral Drugs Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst